Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM225CWN
HER2amp
Basal A
NSC 663284
CDC25
CDC
10579.14
uM
2.24220
3.78720
-0.9927 -0.9999 2.0957 0.5832
0.9989
0.9303
SUM225CWN
HER2amp
Basal A
NU6102
CDK1/2
CDK
12098.147
uM
43.87710
54.63610
-0.4591 -0.9968 4.9999 0.2268
0.8542
1.1904
SUM225CWN
HER2amp
Basal A
Nutlin 3a
MDM2
MDM2
7533.066
uM
15.83360
22.27750
-0.9482 -1.0000 3.2175 0.1961
0.9891
0.8676
SUM225CWN
HER2amp
Basal A
Nutlin 3a
MDM2
MDM2
7534.066
uM
20.6350
33.12770
-0.6725 -1.0000 2.3208 0.1603
0.9915
1.0191
SUM225CWN
HER2amp
Basal A
Olomoucine II
CDK1
CDK
12098.147
uM
5.27270
5.62770
-0.1980 -0.1926 5.0000 0.3237
0.9619
1.1904
SUM225CWN
HER2amp
Basal A
Omipalisib
PI3K
PI3K
10579.087
uM
0.00169
0.00768
-0.8823 -0.6699 0.5607 1.0541
0.9637
0.9622
SUM225CWN
HER2amp
Basal A
Oxamflatin
HDAC
HDAC
12098.147
uM
0.85121
2.73110
-0.9191 -1.0000 0.9424 0.5630
0.9647
1.1904
SUM225CWN
HER2amp
Basal A
PD 98059
MEK
MAPK
12098.159
uM
10.17520
7.80930
0.3290 0.3669 5.0000 0.1714
0.8727
1.0261
SUM225CWN
HER2amp
Basal A
PD 98059
MEK
MAPK
10579.136
uM
24.91990
24.74360
0.0183 0.0174 4.9999 0.0770
0.9827
0.6876
SUM225CWN
HER2amp
Basal A
PD173074
FGFR1/3
RTK
10579.1
uM
13.56940
23.08410
-0.8067 -1.0000 2.0677 0.2038
0.9791
0.9677
SUM225CWN
HER2amp
Basal A
PD184352
MEK
MAPK
12098.155
uM
inf
inf
0.7400 0.7400 0.0000 0.1295
0.3373
1.0503
SUM225CWN
HER2amp
Basal A
PD184352
MEK
MAPK
12098.155
uM
inf
inf
0.7400 0.7400 0.0000 0.1295
0.3373
1.0503
SUM225CWN
HER2amp
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7533.095
uM
inf
inf
0.7658 0.7658 0.0000 0.0600
0.0756
0.9850
SUM225CWN
HER2amp
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7534.095
uM
inf
inf
0.8515 0.8515 0.0000 0.0060
0.2793
0.8052
SUM225CWN
HER2amp
Basal A
PS-1145
IKK
NFKB
7534.065
uM
inf
inf
0.8726 0.8726 0.0000 -0.0301
0.3917
0.9529
SUM225CWN
HER2amp
Basal A
PS-1145
IKK
NFKB
7533.065
uM
inf
inf
0.6455 0.6455 0.0000 0.0965
0.4664
1.0679
SUM225CWN
HER2amp
Basal A
Purvalanol A
CDK1
CDK
7533.067
uM
87.46430
215.85730
0.3519 -0.3881 0.6360 0.0789
0.8937
1.0554
SUM225CWN
HER2amp
Basal A
Purvalanol A
CDK1
CDK
7534.067
uM
21.72610
22.1420
0.0420 -0.0133 1.3846 0.1628
0.9824
1.1276
SUM225CWN
HER2amp
Basal A
Ribavirin
15403.211
uM
inf
inf
0.4799 0.4799 0.0000 0.2473
0.3950
0.7553
SUM225CWN
HER2amp
Basal A
Ro 32-0432
PKC
PKC
10579.142
uM
inf
inf
1.0500 1.0500 0.0000 -0.0168
-0.2942
1.0435
SUM225CWN
HER2amp
Basal A
SB-3CT
MMP2/9
MMP
10579.144
uM
inf
inf
0.8597 0.8597 0.0000 -0.0118
0.3052
0.9576
SUM225CWN
HER2amp
Basal A
SB-3CT
MMP2/9
MMP
12098.144
uM
inf
19.97250
0.7121 0.7120 5.0000 0.0215
0.8105
1.1959
SUM225CWN
HER2amp
Basal A
Selumetinib
MEK
MAPK
12098.155
uM
inf
0.00788
0.8639 0.8687 4.9796 0.0832
0.6381
1.0503
SUM225CWN
HER2amp
Basal A
Sigma A6730
AKT
AKT
10579.141
uM
0.44576
2.38110
-0.9858 -1.0000 0.6557 0.6692
0.8501
0.8894
SUM225CWN
HER2amp
Basal A
Sigma A6730
AKT
AKT
12098.158
uM
0.94124
3.5940
-0.9729 -1.0000 0.8200 0.5030
0.9740
1.1438